Epclusa Revisions for Coinfection Approved

generic Epclusa dr reddys resof total 12 weeks 84 tablets

  • FDA approved coinfections for both HCV and HIV-1 based on ASTRAL-5 clinical trial data.
  • Hepatitis C treatments for genotypes 1, 2,3,4,5 or 6 without compensated cirrhosis could be treated with Epclusa.
  • Epclusa is velpatasvir 100mg and sofosbuvir 400mg for 12 weeks, 84 tablets.
  • 100 patients with HCV genotype 1-6 and HIV-1 were treated with Epclusa for 12 weeks and antiretroviral therapy.
  • 86% were male age 57 years old.
  • Most common adverse events were fatigue and headache.

Generic Epclusa is available here.